Fig. 1. Shroom3 binds ROCKs via its ASD2 domain. (A) Schematic
representation of Shroom3 and its deletion mutants. (B) MDCK-Tet-Off
cell lines inducibly expressing FLAG-tagged, full-length Shroom3 (Shrm-Full)
or Shroom3-
ASD2 (Shrm-
ASD2) were double-immunostained for FLAG
and ZO-1. Expression of these molecules is suppressed in the presence of
doxycycline [Dox(+)], but induced by its removal (Dox[-]) from the culture
medium. The apical cell junctions, delineated by ZO-1 signals, are tightened
by expression of Shrm-Full but not of Shrm-
ASD2. Scale bars: 10 µm.
(C) In vitro interaction of ASD2 with endogenous Rock1 or Rock2.
GST-tagged Shrm-ASD2 or GST was incubated with a MDCK cell lysate, and then
pulled down with Glutathione-Sepharose 4B beads, followed by immunoblotting
with antibodies against Rock1, Rock2,
-tubulin and GST. (D) In
situ interaction of ASD2 with Rock1 or Rock2. COS7 cells were co-transfected
with FLAG-tagged Shrm-ASD2 and HA-tagged Rock1 or Rock2. Cell lysates were
subjected to immunoprecipitation with anti-FLAG antibody, followed by
immunoblotting with anti-HA or anti-FLAG antibody.